ALYSSA SHEPARD: Open Payments
NPI 1578205209 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 13 payments from 8 companies in 2025. Trend: 2023 $917 · 2024 $758 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Novo Nordisk Inc | 2 | $49 |
| ABBVIE INC. | 2 | $45 |
| Medtronic, Inc. | 1 | $41 |
| Amgen Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $23 |
| PFIZER INC. | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: UBRELVY, INTELLIS ADAPTIVESTIM, BREZTRI, OTEZLA, Wegovy, MOUNJARO, NURTEC ODT, Rybelsus.
Industry payments across VA — which companies pay providers there.
